Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Del Marmol, Veronique" or (type exact bookEditor and editor="Del Marmol, Veronique")

Add to list
- Journal Article
- A1
- open access
Immune checkpoint blockade for organ transplant patients with advanced cancer : how far can we go?

Pauline De Bruyn, Dirk Van Gestel, Piet Ost (UGent) , Vibeke Kruse (UGent) , Lieve Brochez (UGent) , Hans Van Vlierberghe (UGent) , Arnaud Devresse, Véronique del Marmol, Alain Le Moine and Sandrine Aspeslagh

(2019) CURRENT OPINION IN ONCOLOGY. 31(2). p.54-64
Add to list
- Journal Article
- A1
- open access
Molecular and epigenetic features of melanomas and tumor immune microenvironment linked to durable remission to ipilimumab-based immunotherapy in metastatic patients

Teofila Seremet, Alexander Koch (UGent) , Yanina Jansen, Max Schreuer, Sofie Wilgenhof, Véronique Del Marmol, Danielle Liènard, Kris Thielemans, Kelly Schats, Mark Kockx, et al.

(2016) JOURNAL OF TRANSLATIONAL MEDICINE. 14.
Add to list
- Conference Paper
- C3
Identification of a predictive signature based on immunohistochemical (IHC), RNA-seq and epigenetic profiling of melanoma metastases for response to ipilimumab-based immunotherapy

Teofila Seremet, Alexander Koch, Sofie Wilgenhof, Max Schreuer, Yanina Jansen, Danielle Lienard, Veronique Del Marmol, Kris Thielemans, Nicolas Van Baren, Pierre Coulie, et al.

(2015) JOURNAL OF CLINICAL ONCOLOGY. 33(15, suppl.).
Add to list
Sox9 controls self-renewal of oncogene targeted cells and links tumor initiation and invasion

Jean-Christophe Larsimont, Khalil Kass Youssef, Adriana Sánchez-Danés, Vijayakumar Sukumaran, Matthieu Defrance, Benjamin Delatte, Mélanie Liagre, Pieter Baatsen, Jean-Christophe Marine, Saskia Lippens (UGent) , et al.

(2015) CELL STEM CELL. 17(1). p.60-73

Academic Bibliography

Immune checkpoint blockade for organ transplant patients with advanced cancer : how far can we go?

Molecular and epigenetic features of melanomas and tumor immune microenvironment linked to durable remission to ipilimumab-based immunotherapy in metastatic patients

Identification of a predictive signature based on immunohistochemical (IHC), RNA-seq and epigenetic profiling of melanoma metastases for response to ipilimumab-based immunotherapy

Sox9 controls self-renewal of oncogene targeted cells and links tumor initiation and invasion

Contents

Support

Contact